Search Page

1

Cite

Share

Dysregulation of Cell Signaling by SARS-CoV-2.

Suryawanshi RK, Koganti R, Agelidis A, Patil CD, Shukla D. Suryawanshi RK, et al. Among authors: koganti r. Trends Microbiol. 2021 Mar;29(3):224-237. doi: 10.1016/j.tim.2020.12.007. Epub 2020 Dec 19. Trends Microbiol. 2021. PMID: 33451855 Free PMC article. Review.

Cite

Share

2

Cite

Share

Pathobiology and treatment of viral keratitis.

Koganti R, Yadavalli T, Naqvi RA, Shukla D, Naqvi AR. Koganti R, et al. Exp Eye Res. 2021 Apr;205:108483. doi: 10.1016/j.exer.2021.108483. Epub 2021 Feb 6. Exp Eye Res. 2021. PMID: 33556334 Free PMC article. Review.

Cite

Share

3

Cite

Share

Heparanase, cell signaling, and viral infections.

Koganti R, Suryawanshi R, Shukla D. Koganti R, et al. Cell Mol Life Sci. 2020 Dec;77(24):5059-5077. doi: 10.1007/s00018-020-03559-y. Epub 2020 May 27. Cell Mol Life Sci. 2020. PMID: 32462405 Free PMC article. Review.

Cite

Share

4

Cite

Share

Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis.

Koganti R, Memon A, Shukla D. Koganti R, et al. Semin Thromb Hemost. 2021 Apr;47(3):283-294. doi: 10.1055/s-0041-1725068. Epub 2021 Apr 1. Semin Thromb Hemost. 2021. PMID: 33851373 Review.

Cite

Share

5

Cite

Share

Herpes Simplex Virus Cell Entry Mechanisms: An Update.

Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D. Madavaraju K, et al. Among authors: koganti r. Front Cell Infect Microbiol. 2021 Jan 18;10:617578. doi: 10.3389/fcimb.2020.617578. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33537244 Free PMC article. Review.

Cite

Share

6

Cite

Share

Vaccines and Therapies in Development for SARS-CoV-2 Infections.

Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D. Wu D, et al. Among authors: koganti r. J Clin Med. 2020 Jun 16;9(6):1885. doi: 10.3390/jcm9061885. J Clin Med. 2020. PMID: 32560227 Free PMC article. Review.

Cite

Share

7

Cite

Share

Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry.

Suryawanshi RK, Patil CD, Koganti R, Singh SK, Ames JM, Shukla D. Suryawanshi RK, et al. Among authors: koganti r. Pathogens. 2021 Jun 24;10(7):803. doi: 10.3390/pathogens10070803. Pathogens. 2021. PMID: 34202835 Free PMC article.

Cite

Share

8

Cite

Share

mTORC2 confers neuroprotection and potentiates immunity during virus infection.

Suryawanshi RK, Patil CD, Agelidis A, Koganti R, Ames JM, Koujah L, Yadavalli T, Madavaraju K, Shantz LM, Shukla D. Suryawanshi RK, et al. Among authors: koganti r. Nat Commun. 2021 Oct 14;12(1):6020. doi: 10.1038/s41467-021-26260-5. Nat Commun. 2021. PMID: 34650053 Free PMC article.

Cite

Share

9

Cite

Share

Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer.

Tiwari V, Koganti R, Russell G, Sharma A, Shukla D. Tiwari V, et al. Among authors: koganti r. Front Immunol. 2021 Jun 14;12:680891. doi: 10.3389/fimmu.2021.680891. eCollection 2021. Front Immunol. 2021. PMID: 34194434 Free PMC article. Review.

Cite

Share

10

Cite

Share

Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections.

Koganti R, Yadavalli T, Shukla D. Koganti R, et al. Microorganisms. 2019 Oct 10;7(10):429. doi: 10.3390/microorganisms7100429. Microorganisms. 2019. PMID: 31658632 Free PMC article. Review.

Cite

Share